Maria J. Perry

Lisbon, 1649003, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Correction: Oliveira et al. Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice. Int. J. Mol. Sci. 2021, 22, 5289.

Correction: Oliveira et al. Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice. Int. J. Mol. Sci. 2021, 22, 5289.

Journal: International journal of molecular sciences

Published: December 31, 2024

Nitroaromatic-based triazene prodrugs to target the hypoxic microenvironment in glioblastoma.

Nitroaromatic-based triazene prodrugs to target the hypoxic microenvironment in glioblastoma.

Journal: RSC medicinal chemistry

Published: November 09, 2024

A step forward on the in vitro and in vivo assessment of a novel nanomedicine against melanoma.

A step forward on the in vitro and in vivo assessment of a novel nanomedicine against melanoma.

Journal: International journal of pharmaceutics

Published: December 27, 2022

Preclinical validation of a new hybrid molecule loaded in liposomes for melanoma management.

Preclinical validation of a new hybrid molecule loaded in liposomes for melanoma management.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 17, 2022

Sulfur Analogues of Tyrosine in the Development of Triazene Hybrid Compounds: A New Strategy against Melanoma.

Sulfur Analogues of Tyrosine in the Development of Triazene Hybrid Compounds: A New Strategy against Melanoma.

Journal: ACS medicinal chemistry letters

Published: April 27, 2021

Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice.

Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice.

Journal: International journal of molecular sciences

Published: April 16, 2021

Anticancer Triazenes: from Bioprecursors to Hybrid Molecules.

Anticancer Triazenes: from Bioprecursors to Hybrid Molecules.

Journal: Current pharmaceutical design

Published: February 28, 2019

Targeting gliomas with triazene-based hybrids: Structure-activity relationship, mechanistic study and stability.

Targeting gliomas with triazene-based hybrids: Structure-activity relationship, mechanistic study and stability.

Journal: European journal of medicinal chemistry

Published: January 28, 2019

Endoperoxide-8-aminoquinoline hybrids as dual-stage antimalarial agents with enhanced metabolic stability.

Endoperoxide-8-aminoquinoline hybrids as dual-stage antimalarial agents with enhanced metabolic stability.

Journal: European journal of medicinal chemistry

Published: November 08, 2017

The selective cytotoxicity of new triazene compounds to human melanoma cells.

The selective cytotoxicity of new triazene compounds to human melanoma cells.

Journal: Bioorganic & medicinal chemistry

Published: March 10, 2017

Targeting Gliomas: Can a New Alkylating Hybrid Compound Make a Difference?

Targeting Gliomas: Can a New Alkylating Hybrid Compound Make a Difference?

Journal: ACS chemical neuroscience

Published: September 27, 2016

Enantiopure Indolizinoindolones with in vitro Activity against Blood- and Liver-Stage Malaria Parasites.

Enantiopure Indolizinoindolones with in vitro Activity against Blood- and Liver-Stage Malaria Parasites.

Journal: ChemMedChem

Published: September 17, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026